Trial intelligence / Profile preview

Covert Consciousness During Dexmedetomidine and Ketamine Sedation

NCT07705022Phase 2Enrolling by invitation

Sponsor
University of Michigan
Start
Aug 2026
Primary completion
Jan 2028
Countries
1
01

Overview

A Phase 2 trial of dexmedetomidine, ketamine, sponsored by University of Michigan. Started Aug 2026; status: enrolling by invitation.

02

Drugs

dexmedetomidineketamine

Beyond the preview

Go deeper on NCT07705022.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07705022.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call